Co-Diagnostics announced that use of the Company’s vector control technology will expand to the 15th U.S. state following an installation in Nevada next week. Co-Dx vector control technology includes Vector Smart PCR tests used in environmental surveillance of mosquito pools for mosquito-borne illnesses like West Nile virus, Zika, dengue and chikungunya. Mosquito abatement districts and other vector control customers can use Vector Smart tests as well as other equipment sold and installed by Co-Diagnostics to receive same-day results of mosquito pool testing, allowing for quicker and more efficient prevention of disease transmission to humans and animals.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CODX:
- Co-Diagnostics submits FDA 510(k) application for Co-Dx PCR Pro platform
- Co-Diagnostics completes first FDA 510(k) application for Co-Dx PCR Pro
- Co-Diagnostics price target lowered to $2 from $2.50 at H.C. Wainwright
- Co-Diagnostics reports Q1 EPS (31c) vs. (20c) last year
- Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results